Caulerpin as a potential antiviral drug against herpes simplex virus type 1

Revista Brasileira de Farmacognosia

Nathália Regina Porto Vieira Macedo²  Michele S. Ribeiro²  Roberto C. Villaça¹  Wilton Ferreira¹  Ana Maria Pinto²  Valéria L. Teixeira¹  Claudio Cirne-santos²  Izabel C. N. P. Paixão²  Viveca Giongo² 

[1] ,Universidade Federal Fluminense Instituto de Biologia Departamento de Biologia Celular e Molecular,Brazil

关键词: Caulerpa;    caulerpin;    Herpes simplex type 1;    cytotoxicity;    antiviral;   

DOI  :  10.1590/S0102-695X2012005000072

来源: SciELO

【 摘 要 】

About 80% of the human adult population is infected with HSV-1. Although there are many anti-HSV-1 drugs available (acyclovir, ganciclovir, valaciclovir, foscarnet), their continuous use promotes the selection of resistant strains, mainly in ACV patients. In addition to resistance, the drugs also have toxicity, particularly when administration is prolonged. The study of new molecules isolated from green algae with potential antiviral activity represents a good opportunity for the development of antiviral drugs. Caulerpin, the major product from the marine algae Caulerpa Lamouroux (Caulerpales), is known for its biological activities such as antioxidant, antifungal, acetylcholinesterase inhibitor (AChE) and antibacterial activity. In this work, we show that caulerpin could be an alternative to acyclovir as an anti-HSV-1 drug that inhibits the alpha and beta phases of the replication cycle.

【 授权许可】

CC BY-NC-ND   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License